| Share: 
KidneyX launches Artificial Kidney Prize to radically transform kidney care
The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) have launched the KidneyX Artificial Kidney Prize, a competition to accelerate the development of artificial kidneys toward human clinical trials. This multiphase competition is KidneyX’s first fully dedicated effort toward artificial kidney advancement, with initial phases offering up to $10 million in prizes.
The Artificial Kidney Prize builds on past KidneyX competitions but is distinct in its goal: to accelerate the development of continuous kidney replacement therapies that provide transformational treatment options beyond current dialysis methods. Artificial kidneys may be wearable, implantable, bioengineered, developed as a xenotransplant or chimera organ, or other approaches not yet conceived.
The Artificial Kidney Prize is open to both U.S. and international entrants, subject to eligibility requirements. Innovators across expertise disciplines — including bioengineering, nanotechnology, materials science, regenerative medicine, and medical devices are encouraged to participate. The first phase seeks component or integrated prototype solutions that enable and advance the functionality, effectiveness, and/or reliability of artificial kidneys. Phase 1 submissions are due by March 24, 2021.
Phase 1 seeks solutions that enable and advance the functionality, effectiveness, and/or reliability of artificial #kidneys. Entrants can explore teaming opportunities by joining the #KidneyX solver community: https://akp.kidneyx.org/solver-community/.
To learn more about the competition and teaming opportunities, prospective entrants can replay the December 3 information session.
